《公司業績》利興發展(00068.HK)全年虧損收窄至4.46億元
利興發展(00068.HK)公布截至去年12月底止全年業績,營業額1,702.4萬元,按年跌15.6%。虧損收窄至4.46億元,上年同期蝕4.82億元;每股虧損304.19仙。不派息。
核數師就報告發表保留意見,指無法為有關該兩項投資確認於綜合損益表中的公平值轉變,包括分別在綜合損益表中「按公平值計入損益之財務資產–上市投資之淨虧損」的出售PureCircle Limited股本權益之虧損3.03億元,及「收入及收益」的出售Ingredion SRSS Holdings Limited之B普通股之溢利911.8萬元的準確性取得適當的憑證。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.